Wave Life Sciences Ltd. - Ordinary Shares, no par value (WVE)

CUSIP: Y95308105

Q2 2016 13F Holders as of 30 Jun 2016

Type / Class
Equity / Ordinary Shares, no par value
Shares outstanding
182,917,028
Total 13F shares
14,199,612
Share change
+199,020
Total reported value
$293,778,139
Price per share
$20.69
Number of holders
37
Value change
+$6,802,315
Number of buys
28
Number of sells
10

Quarterly Holders Quick Answers

What is CUSIP Y95308105?
CUSIP Y95308105 identifies WVE - Wave Life Sciences Ltd. - Ordinary Shares, no par value in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Wave Life Sciences Ltd. - Ordinary Shares, no par value (WVE) as of Q2 2016

As of 30 Jun 2016, Wave Life Sciences Ltd. - Ordinary Shares, no par value (WVE) was held by 37 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 14,199,612 shares. The largest 10 holders included RA CAPITAL MANAGEMENT, LLC, FMR LLC, Redmile Group, LLC, Foresite Capital Management III, LLC, New Leaf Venture Partners, L.L.C., PERCEPTIVE ADVISORS LLC, Cormorant Asset Management, LLC, EVENTIDE ASSET MANAGEMENT, LLC, Clough Capital Partners L P, and BlackRock Fund Advisors. This page lists 37 institutional shareholders reporting positions in this security for the Q2 2016 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.